124 related articles for article (PubMed ID: 3896369)
1. Serial prostatic histology. A valid marker of response to hormone treatment.
Bishop MC; Ansell ID; Taylor MC; Thomas AL
Br J Urol; 1985 Aug; 57(4):453-7. PubMed ID: 3896369
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
3. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
Smith PH; Robinson M; Richards B; Suciu S; De Pauw M; Sylvester R; Denis L
Urology; 1984 Jun; 23(6 Suppl):64-8. PubMed ID: 6375083
[No Abstract] [Full Text] [Related]
4. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
Benson RC
Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
[No Abstract] [Full Text] [Related]
5. Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.
Bishop MC; Selby C; Taylor M
Br J Urol; 1985 Oct; 57(5):542-7. PubMed ID: 3904908
[TBL] [Abstract][Full Text] [Related]
6. The treatment of disseminated prostate cancer with estramustine.
Rosenthal MA; Raghavan D; Stuart-Harris R; Ackland S; Grygiel J
Aust N Z J Surg; 1992 Nov; 62(11):871-3. PubMed ID: 20169706
[TBL] [Abstract][Full Text] [Related]
7. Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: a randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate. The Dutch Estracyt Study Group.
Janknegt RA; Boon TA; van de Beek C; Grob P
Urology; 1997 Mar; 49(3):411-20. PubMed ID: 9123707
[TBL] [Abstract][Full Text] [Related]
8. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
Benson RC; Cummings K
Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
[No Abstract] [Full Text] [Related]
9. Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.
Smith DC; Esper P; Strawderman M; Redman B; Pienta KJ
J Clin Oncol; 1999 Jun; 17(6):1664-71. PubMed ID: 10561202
[TBL] [Abstract][Full Text] [Related]
10. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
12. Do bone scans predict prognosis in prostatic cancer? A report of the EORTC protocol 30762.
Lund F; Smith PH; Suciu S
Br J Urol; 1984 Feb; 56(1):58-63. PubMed ID: 6697108
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of advanced prostate cancer].
Murphy GP
Vopr Onkol; 1977; 23(12):26-38. PubMed ID: 146305
[No Abstract] [Full Text] [Related]
14. Change in white cell count during treatment of advanced cancer of the prostate with estramustine phosphate and with stilboestrol.
Daponte D; Sylvester R; De Pauw M; Fryszman A; Smith RM; Smith PH
Br J Urol; 1983 Aug; 55(4):408-12. PubMed ID: 6349745
[TBL] [Abstract][Full Text] [Related]
15. The questionable use of hormone therapy in advanced carcinoma of the prostate.
Murphy GP; Slack NH
Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
[No Abstract] [Full Text] [Related]
16. A transient increase in serum procollagen 1 carboxyterminal peptide following effective treatment in prostate cancer patients with bone metastases.
Nakashima J; Sumitomo M; Miyajima A; Jitsukawa S; Murai M
Urol Int; 1997; 58(4):236-8. PubMed ID: 9253125
[TBL] [Abstract][Full Text] [Related]
17. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Hauchecorne J
Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
[No Abstract] [Full Text] [Related]
18. [Effect of estramustine phosphate on hormone refractory prostate cancer].
Tanaka M; Shiomi K; Hamano S; Suzuki N; Igarashi T; Murakami S; Shimazaki J
Hinyokika Kiyo; 1997 Mar; 43(3):245-50. PubMed ID: 9127765
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
de Voogt HJ; Suciu S; Sylvester R; Pavone-Macaluso M; Smith PH; de Pauw M
J Urol; 1989 Apr; 141(4):883-8. PubMed ID: 2522561
[TBL] [Abstract][Full Text] [Related]
20. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
Benson RC; Gill GM; Cummings KB
Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
